SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-043409
Filing Date
2020-09-14
Accepted
2020-09-14 16:01:31
Documents
6
Period of Report
2020-09-14

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20200914.htm 6-K 31819
2 EX-99.1 lmnl-ex991_8.htm EX-99.1 32672
3 EX-99.2 lmnl-ex992_45.htm EX-99.2 43598
4 EX-99.3 lmnl-ex993_74.htm EX-99.3 19829
5 GRAPHIC g3vl4u5hvd1n000001.jpg GRAPHIC 38195
6 GRAPHIC gwn3nxepgr5l000001.jpg GRAPHIC 4665
  Complete submission text file 0001564590-20-043409.txt   188354
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 201173189
SIC: 2834 Pharmaceutical Preparations